U.S. Markets close in 3 hrs 42 mins

Cardlytics, Inc. (CDLX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.78-0.40 (-4.36%)
As of 12:17PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.18
Bid8.78 x 800
Ask8.79 x 900
Day's Range8.68 - 9.17
52 Week Range8.68 - 97.21
Avg. Volume670,314
Market Cap292.104M
Beta (5Y Monthly)2.44
PE Ratio (TTM)N/A
EPS (TTM)-2.04
Earnings DateOct 31, 2022 - Nov 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.00
  • Insider Monkey

    10 Best Stocks to Buy According to Ari Zweiman’s 683 Capital Partners

    In this article, we present the list of top 10 stock picks of Ari Zweiman’s 683 Capital Partners at the end of the second quarter. If you want to skip the fund’s history, recent performance and details about its overall portfolio, please go directly to 5 Best Stocks to Buy According to Ari Zweiman’s 683 […]

  • GlobeNewswire

    Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    ATLANTA, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced that, on September 1, 2022, Cardlytics’ Board of Directors granted 1,345,261 restricted stock units of Cardlytics to Karim Temsamani, Cardlytics’ newly hired Chief Executive Officer. The foregoing restricted stock units were granted as a material inducement to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted

  • Motley Fool

    Cardlytics, Inc. (CDLX) Q2 2022 Earnings Call Transcript

    Thank you for standing by, and welcome to the second quarter 2022 Cardlytics, Inc. earnings conference call. For a discussion of the specific risk factors that could cause our actual results to differ materially from today's discussion, please refer to the risk factors section of the company's 10-Q for the quarter ended June 30, 2022, which has been filed with the Securities and Exchange Commission.